Targeting MitoNEET with Pioglitazone for Therapeutic Neuroprotection After Spinal Cord Injury

Authors

Alexander G. Rabchevsky, University of KentuckyFollow
Samir P. Patel, University of KentuckyFollow
Patrick G. Sullivan, University of KentuckyFollow

Document Type

Article

Publication Date

11-2017

Notes/Citation Information

Published in Neural Regeneration Research, v. 12, issue 11, p. 1807-1808.

This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under identical terms.

Digital Object Identifier (DOI)

https://doi.org/10.4103/1673-5374.219040

Funding Information

This work was funded by NIH R21NS096670 (AGR), Craig H. Neilsen Foundation 476719 (AGR), Kentucky Spinal Cord and Head Injury Research Trust #15-14A (PGS), Veterans Affairs Merit Review Award #I01BX003405 (PGS), University of Kentucky Spinal Cord and Brain Injury Center Chair Endowments (AGR & PGS), NIH/NINDS 2P30NS051220.

Repository Citation

Rabchevsky, Alexander G.; Patel, Samir P.; and Sullivan, Patrick G., "Targeting MitoNEET with Pioglitazone for Therapeutic Neuroprotection After Spinal Cord Injury" (2017). Spinal Cord and Brain Injury Research Center Faculty Publications. 20.
https://uknowledge.uky.edu/scobirc_facpub/20